Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma.

Lederle W, Hartenstein B, Meides A, Kunzelmann H, Werb Z, Angel P, Mueller MM.

Carcinogenesis. 2010 Jul;31(7):1175-84. doi: 10.1093/carcin/bgp248. Epub 2009 Nov 5.

2.

Effects of selective MMP-13 inhibition in squamous cell carcinoma depend on estrogen.

Meides A, Gutschalk CM, Devel L, Beau F, Czarny B, Hensler S, Neugebauer J, Dive V, Angel P, Mueller MM.

Int J Cancer. 2014 Dec 15;135(12):2749-59. doi: 10.1002/ijc.28866. Epub 2014 Aug 7.

4.

Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells.

Mueller MM, Fusenig NE.

Differentiation. 2002 Dec;70(9-10):486-97. Review.

PMID:
12492491
5.

Reversion of tumor phenotype in surface transplants of skin SCC cells by scaffold-induced stroma modulation.

Willhauck MJ, Mirancea N, Vosseler S, Pavesio A, Boukamp P, Mueller MM, Fusenig NE, Stark HJ.

Carcinogenesis. 2007 Mar;28(3):595-610. Epub 2006 Oct 19.

PMID:
17056607
6.

Platelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomas.

Lederle W, Linde N, Heusel J, Bzyl J, Woenne EC, Zwick S, Skobe M, Kiessling F, Fusenig NE, Mueller MM.

Am J Pathol. 2010 Feb;176(2):981-94. doi: 10.2353/ajpath.2010.080998. Epub 2009 Dec 30.

7.

Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.

Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litwin S, Herlyn M.

Clin Cancer Res. 1999 Apr;5(4):775-82.

8.

Distinct progression-associated expression of tumor and stromal MMPs in HaCaT skin SCCs correlates with onset of invasion.

Vosseler S, Lederle W, Airola K, Obermueller E, Fusenig NE, Mueller MM.

Int J Cancer. 2009 Nov 15;125(10):2296-306. doi: 10.1002/ijc.24589.

9.

Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.

Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF.

Clin Cancer Res. 1999 May;5(5):1041-56.

10.
11.

A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours.

Beck B, Driessens G, Goossens S, Youssef KK, Kuchnio A, Caauwe A, Sotiropoulou PA, Loges S, Lapouge G, Candi A, Mascre G, Drogat B, Dekoninck S, Haigh JJ, Carmeliet P, Blanpain C.

Nature. 2011 Oct 19;478(7369):399-403. doi: 10.1038/nature10525.

PMID:
22012397
12.

Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.

Zheng HC, Takahashi H, Murai Y, Cui ZG, Nomoto K, Miwa S, Tsuneyama K, Takano Y.

Br J Cancer. 2006 Nov 20;95(10):1371-8. Epub 2006 Oct 31.

13.

Bone marrow-derived myofibroblasts are the providers of pro-invasive matrix metalloproteinase 13 in primary tumor.

Lecomte J, Masset A, Blacher S, Maertens L, Gothot A, Delgaudine M, Bruyère F, Carnet O, Paupert J, Illemann M, Foidart JM, Lund IK, Høyer-Hansen G, Noel A.

Neoplasia. 2012 Oct;14(10):943-51.

14.

Highly invasive melanoma cells activate the vascular endothelium via an MMP-2/integrin αvβ5-induced secretion of VEGF-A.

Desch A, Strozyk EA, Bauer AT, Huck V, Niemeyer V, Wieland T, Schneider SW.

Am J Pathol. 2012 Aug;181(2):693-705. doi: 10.1016/j.ajpath.2012.04.012. Epub 2012 May 31.

PMID:
22659470
16.

Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling.

Donnini S, Monti M, Castagnini C, Solito R, Botta M, Schenone S, Giachetti A, Ziche M.

Int J Cancer. 2007 Mar 1;120(5):995-1004.

17.

Rapid vessel regression, protease inhibition, and stromal normalization upon short-term vascular endothelial growth factor receptor 2 inhibition in skin carcinoma heterotransplants.

Miller DW, Vosseler S, Mirancea N, Hicklin DJ, Bohlen P, Völcker HE, Holz FG, Fusenig NE.

Am J Pathol. 2005 Nov;167(5):1389-403.

18.
19.

Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.

Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G.

Cancer Res. 2003 Jun 15;63(12):3403-12.

20.

Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression.

Nielsen BS, Egeblad M, Rank F, Askautrud HA, Pennington CJ, Pedersen TX, Christensen IJ, Edwards DR, Werb Z, Lund LR.

PLoS One. 2008 Aug 13;3(8):e2959. doi: 10.1371/journal.pone.0002959.

Supplemental Content

Support Center